Skip to main content
Clinical Trials/EUCTR2021-002625-20-BE
EUCTR2021-002625-20-BE
Active, not recruiting
Phase 1

Intrathecal morphine administration for minimally invasive pancreatic surgery: A double blind, prospective randomized placebo-controlled trial. - IT morphine for MIPS

niversity Hospitals Leuven0 sites128 target enrollmentJune 15, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
postoperative pain treatment after minimally invasive pancreatic surgery
Sponsor
niversity Hospitals Leuven
Enrollment
128
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 15, 2021
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversity Hospitals Leuven

Eligibility Criteria

Inclusion Criteria

  • \- 18\-80 years of age
  • \-BMI \= 40 kg/m2
  • \-Patient is able to give informed consent
  • \-Patient understands the use of morphine PCIA
  • \-Patient is scheduled for elective minimally invasive pancreatic surgery
  • \-ASA I\-IV
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 64

Exclusion Criteria

  • \- Refusal to participate in the trial
  • \-Inability to operate a PCIA system
  • \-Chronic opioid use, or chronic pain patient
  • \-Obstructive sleep apnea syndrome (OSAS) requiring CPAP therapy
  • \-If patient is known with kidney disease or renal dysfunction, the GFR will be checked and patient will be excluded if GFR \< 30 mL/min.
  • \-Neuraxial anesthesia will only be performed with normal clotting lab results (UZ Leuven):
  • \-Thrombocytes \= 80 x 109/L
  • \-INR \= 1,5
  • \-aPTT (s) \= 31
  • \-Presence of contra\-indications for spinal anesthesia (patients on anticoagulants, coagulation deficits, severe spinal canal stenosis, neurological deficits, increased intracranial pressure, severe aortic stenosis as defined by aortic valve area (AVA) \< 1 cm2\)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Effect of low-dose intrathecal (within the spinal space) morphine as a part of multimodal analgesia (which combines various groups of medications for pain relief) in patients aged 18 to 65 years undergoing cardiac surgery by cutting of breast bone.
CTRI/2024/06/068299All India Institute of Medical Sciences
Active, not recruiting
Phase 1
The effect of spinally administered morphine on pain after total knee arthroplastyPostoperative pain after total knee arthroplastyMedDRA version: 20.0 Level: LLT Classification code 10003398 Term: Arthroplasty of knee System Organ Class: 100000021309Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
EUCTR2017-002170-39-FIEksote120
Not yet recruiting
Phase 4
To asses the effect of spinal morphine on inflammatory markers and clinical outcome in patients undergoing open heart surgeryHealth Condition 1: I39- Endocarditis and heart valve disorders in diseases classified elsewhereHealth Condition 2: I978- Other intraoperative and postprocedural complications and disorders of the circulatory system, not elsewhere classified
CTRI/2023/07/055338All India Institute of Medical sciences
Not yet recruiting
Not Applicable
It is randomized controlled trial to know the efficacy of intrathecal morphine combined with 0.75% ropivacaine heavy for postoperative analgesia in laparoscopic cholecystectomy.
CTRI/2022/08/045034A
Active, not recruiting
Not Applicable
Intrathecal Morphine for pain management in patients undergoing major abdominal surgery: The optimal dose?
EUCTR2004-005222-41-GBHCW NHS Trust100